Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ZS vs GSK✓SelectedUSD · GSKZS vs GSK performance historyLatest closeAs of-0.39%11/13
Stock and ETF performance explorer

ZS vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-44.3%
GSK return
+44.4%
Excess return
-88.8%
Maximum drawdown
-76.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.4%+0.5%-0.9%-0.4%
7D-2.6%+1.1%-3.8%-2.7%
30D-12.8%+6.3%-19.2%-13.3%
3M+2.3%+1.8%+0.5%+2.1%
6M+26.3%+1.7%+24.6%+25.9%
YTD-14.4%+6.5%-21.0%-16.4%
1Y-37.6%+9.5%-47.1%-39.4%
3Y+8.0%+65.3%-57.3%-5.8%
All-44.3%+44.4%-88.8%-52.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling